论文部分内容阅读
目的 探讨支气管动脉化疗并栓塞治疗肺癌的价值。方法 对照组(A组)30例中晚期肺癌行支气管动脉灌注(BAI);实验组(B组)30例中晚期肺癌使用3F微导管行肺癌靶动脉的灌注+栓塞(BAI+BAE)。药物:卡铂、表阿霉素、丝裂霉素等。栓塞剂:超液化碘油。结果 A组肿块明显缩小者40％,部分缩小者48％,无变化12％,总有效率88％;B组肿块明显缩小者83％,部分缩小者17％,总有效率100％。结论 BAI+BAE较单纯BAI能明确提高疗效,使用3F微导管能明显减少并发症的发生。
Objective To investigate the value of bronchial arterial chemotherapy and embolization in the treatment of lung cancer. Methods Bronchial arterial infusion (BAI) was performed in 30 patients with advanced lung cancer in the control group (A group) and BAI + BAE in 30 patients with lung cancer in the experimental group (B group). Drugs: carboplatin, epirubicin, mitomycin, etc. Embolic agent: Lipiodol. Results In the A group, the mass was significantly reduced by 40%, partially reduced by 48%, unchanged by 12%, and the total effective rate was 88%. In the B group, the mass was significantly reduced by 83%, partially reduced by 17%, and the total effective rate was 100%. Conclusions Compared with BAI alone, BAI+BAE can definitely improve the therapeutic effect. The use of 3F microcatheter can significantly reduce the occurrence of complications.